Overview:

The global HPV testing market is valued for more than US$ XXX.X Mn in 2019 and expected to reach a value of US$ XXX.X Mn by 2029 with a significant CAGR of around XX.X% over the forecast period of 2019-2029. Human Papillomavirus (HPV) is a known group of viruses. This virus has tendency to cause papilloma or warts. Also, some virus among these HPV may result in cancer. There are two key type of this viruses that is high risk genital and low risk genital HPV. HPV testing helps to identify the presence of HPV in the cervix of women.

Market Dynamics:

Rising prevalence of cervical cancer among female population and rising hospital admissions for various type of cancer across the globe are major factors driving growth of the global HPV testing market. For instance, According to U.S. Department of Health and Human Services the rate of new cases of cervical cancer was 7.4 per 100,000 women per year and the death rate was 2.3 per 100,000 women per year dated from 2013-2017. Also, growing government spending on development of healthcare infrastructure for reliable diagnosis and accurate test results are other key factors expected to drive growth of the global market.

In addition, availability of favorable reimbursement policies is another factor expected to further support the growth of target market in developed countries. However, factors such as developing stringent regulations related with product approvals is a key factor expected to hamper growth of the global HPV testing market to a certain extent. Moreover, lack of reimbursement policies in developing countries is another factor expected to challenge growth of the target market.

Key Trends:

Rising investment for R&D activities and introduction of novel kits by key players is a key trend witnessed in the global HPV testing market. For example, in April 2020 Roche Diagnostics has received approval for cobas HPV test from the US FDA. The cobas HPV test is helps to identify women at risk for cervical cancer by detecting the presence of high-risk human papillomavirus (HPV) DNA in cervical samples.

Regional Analysis:

For detailed understanding of market dynamics, the global HPV testing market is analyzed across key regions viz. North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North America region is expected to hold significant revenue share in the global market, owing to increasing patient pool suffering from chronic disease, high spending capacity on personal health, and availability of reimbursement policy in countries in the region.

In addition, the presence of major players and high adoption for novel product offerings are among other factors expected to further support growth of the target market. However, the Europe expected to hold second largest market share followed by Asia Pacific region in the target market.

Scope of the Report:

Detailed Segmentation:

Global HPV Testing Market, By Type:

• DNA based Test
• RNA based Test

Global HPV Testing Market, By Application:

• Molecular Diagnostics
• Research

Global HPV Testing Market, By End User:

• Hospitals
• Diagnostic Centers
• Clinics
• Other End Users

Key Players Covered:

Key players operating in the global market include, Roche Diagnostics (F. Hoffmann-La Roche AG), Qiagen N.V., Agilent Technologies, Inc., Becton, Dickinson and Company, Abbott Laboratories, Cepheid Inc., Thermo Fisher Scientific Inc., Hologic Inc., Seegene Inc., and Takara Bio Inc.

Key Features of the Study:

Foresight Market Research provides detailed analysis on global market in our report- Global HPV Testing Market by type, application, end user, and region. The report provides market size (US$ Mn) and compounded annual growth rate (%) for the forecast period: 2019 – 2029, considering 2018 as the actual year. The report also contains in-depth analysis about market drivers, restraints, opportunities, new product launches, product approval, ongoing trends, and regional outlook. The report delivers competitive analysis about leading players in the global HPV testing market based on various parameters such as company overview, product portfolio, regional presence, financial performance, distribution strategies, key developments, marketing strategies, and future plans. The analysis from the report would acquaint the marketers and management authorities of companies to make the appropriate decision with respect to their future product launch, market expansion, and marketing tactics used overall the globe.